Clinical Trials Browser

Phase 1/2 × Interventional × entrectinib × Clear all

Thyroid Cancer, Papillary, Brain Neoplasms, Glioma, Medulloblastoma, Neoplasm Metastasis, Wilms Tumor, Neuroblastoma, Recurrence, Salivary Gland Neoplasms, Sarcoma, Sarcoma, Ewing, Central Nervous System Neoplasms, Nephroma, Mesoblastic

NCT04589832 2023-11-22

Study of PAC-1 and Entrectinib for Patients With Metastatic Uveal Melanoma

Phase 1/2 Terminated

6 enrolled 9 charts

Dermatologic

Uveal Melanoma

Clinical Trials

STARTRK-NG

Study of PAC-1 and Entrectinib for Patients With Metastatic Uveal Melanoma